Heiko Bruhn will be attending Connect in Pharma 14 & 15 September | Palexpo, GenevaRead more “Connect in Pharma”
It was a great pleasure to celebrate GenSearch’s 10+2 anniversary. Watching the sunset on the Seine with a cool summer breeze with so many of you was just perfect!Read more “GenSearch’s 10+2 anniversary”
Meet Heiko Bruhn at the 19TH ANNUAL BIOTECH IN EUROPE FORUM in Basel.
The 19th Annual Biotech in Europe Forum is recognised as the leading international stage for those interested in investing and partnering in the biotech and life science industry. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives.
The #Sachs_BEF19 forum will be held for the sixth time in Basel to be close to the largest biopharma hub in Europe and the Congress Center provides meeting space capable of handling several thousand one-to-one meetings as well as significant exhibition space. The programme will feature a number of plenary panels/workshops covering BD & Licensing in the main therapeutic areas.
Date: 25TH-26TH SEPTEMBER 2019
Venue: CONGRESS CENTER BASEL, SWITZERLAND
THE NEXT TRANSFORMATION IN HEALTHCARE
The early morning runs, aching limbs and blisters won’t stop the GenSearch team who are determined to run and support the ENDOmind 10km run in Paris to raise awareness for Endometriosis as well as helping to fund further research into this debilitating illness to which there is no known cure.
Join us at the Nordic Life Science Days
Créé il y a cinq ans, le Technology Venture Master’s Program va évoluer à la rentrée prochaine pour devenir un parcours co-porté par l’École polytechnique et HEC. Objectif : former des entrepreneurs de la Deep Tech, et les pousser à « penser grand ». Rencontre avec Bruno Martinaud, son directeur.
The Team will be attending – The Startups Guide to Prototyping: The Consumer is Always Right
Heiko Bruhn will be representing GenSearch in Zurich.
This white paper was written following our Life Science Talks which we organised in 2017, entitled “Innovation in Healthcare: What is the Point?